Effect of stereotactic body radiotherapy on regional metabolic liver function investigated in patients by dynamic [(18)F]FDGal PET/CT

PURPOSE: Stereotactic body radiotherapy (SBRT) is increasingly used for treatment of liver tumors but the effect on metabolic liver function in surrounding tissue is largely unknown. Using 2-deoxy-2-[(18)F]fluoro-d-galactose ([(18)F]FDGal) positron emission tomography (PET)/computed tomography (CT),...

Full description

Bibliographic Details
Main Authors: Sørensen, Michael, Fode, Mette Marie, Petersen, Jørgen Baltzer, Holt, Marianne Ingerslev, Høyer, Morten
Format: Online Article Text
Language:English
Published: BioMed Central 2021
Subjects:
Research
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485519/
https://www.ncbi.nlm.nih.gov/pubmed/34598730
http://dx.doi.org/10.1186/s13014-021-01909-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485519/
https://www.ncbi.nlm.nih.gov/pubmed/34598730
http://dx.doi.org/10.1186/s13014-021-01909-z

Similar Items